ARIAD to Present at the 2011 Deutsche Bank BioFEST

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the 2011 Deutsche Bank BioFEST conference in Boston. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's oncology pipeline on Monday, December 5 at 10:45 a.m. (ET).

The ARIAD presentation at the 2011 Deutsche Bank BioFEST will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks.

About ARIAD

ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD's approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant and difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. For additional information, visit http://www.ariad.com.